Growth Metrics

Incyte (INCY) EBT Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 48,476.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 441.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -408.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 7,297.00
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 2,059.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,059.00
Dec 31, 2025 1,718.00
Sep 30, 2025 1,726.00
Jun 30, 2025 2,074.00
Mar 31, 2025 1,262.00
Dec 31, 2024 1,271.00
Sep 30, 2024 -1,201.00
Jun 30, 2024 -6,166.00
Mar 31, 2024 1,535.00
Dec 31, 2023 545.00
Sep 30, 2023 2,601.00
Jun 30, 2023 -1,558.00
Mar 31, 2023 13,026.00
Dec 31, 2022 -1,305.00
Sep 30, 2022 -879.00
Jun 30, 2022 466.00
Mar 31, 2022 -1,129.00
Dec 31, 2021 53.00
Sep 30, 2021 1,888.00
Jun 30, 2021 1,396.00
Mar 31, 2021 2,202.00
Dec 31, 2020 5,468.00
Sep 30, 2020 -1,193.00
Jun 30, 2020 4,753.00
Mar 31, 2020 -7,230.00
Dec 31, 2019 1,885.00
Sep 30, 2019 1,262.00
Jun 30, 2019 621.00
Mar 31, 2019 1,163.00
Dec 31, 2018 -945.00
Sep 30, 2018 2,798.00
Jun 30, 2018 457.00
Mar 31, 2018 74.00
Dec 31, 2017 -338.00
Sep 30, 2017 -1,860.00
Jun 30, 2017 3,408.00
Mar 31, 2017 -1,378.00
Dec 31, 2016 4,692.00
Sep 30, 2016 4,004.00
Jun 30, 2016 1,676.00
Mar 31, 2016 3,126.00
Dec 31, 2015 627.00
Sep 30, 2015 1,475.00
Jun 30, 2015 104.00
Mar 31, 2015 11,426.00
Dec 31, 2014 16,065.00
Sep 30, 2014 34,624.00
Jun 30, 2014 27,159.00
Mar 31, 2014 4,516.00
Dec 31, 2013 -8,192.00
Sep 30, 2013 16,596.00
Jun 30, 2013 -923.00
Mar 31, 2013 18,279.00